New Details on the Revision of USP Chapter 1
Recommendation
Thursday, 12 February 2026 9 .00 - 17.00 h
Best Practice for Manual and Automated Visual Inspection of Parenterals
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
04.02.2026Endotoxins Testing: Potential Change for WFI and Steam in the USP
04.02.2026Microbiological Deviations and Technical Deficiencies - Warning Letter to US Manufacturer
28.01.2026Changes to the 'Water Monographs' in the European Pharmacopoeia
21.01.2026Deficient Water System: Warning Letter to US Manufacturer
17.12.2025FDA publishes new Draft Guideline on GMP for Medical Gases
10.12.2025VDI 6022 Sheet 8.1 published: Qualification for the cleaning of air-conditioning systems